CTNow: Education and teleconference support for rural cancer patients and their providers
Official title: CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
Run by University of Hawaii · NCT06237816 · Data updated 2026-11-12
This program tests whether patient and provider education plus teleconference support helps adults with cancer in rural Hawaii get information and referrals for cancer clinical trials.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University of Hawaii Academic / other |
| Locations | 3 sites (Hilo, Hawaii and 2 other locations) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | July 2026 |
| Study ends | December 2026 |
| Registry record updated | April 3, 2026 |
| Trial ID | NCT06237816 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (18+) diagnosed with any cancer who live in Hawaii, Kauai, or Maui counties, can read and speak English, are receiving or about to start cancer treatment (within 90 days) or have recently received treatment, and have not previously participated in a cancer clinical trial.
✕Probably not a fit
Patients who live outside the specified Hawaii counties, are under 18, cannot use English-language materials or phone calls, or have already participated in a cancer clinical trial are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
CTNow is a pilot, multilevel intervention that combines patient education, provider education, and teleconference resources to improve access and referrals to cancer clinical trials in rural areas. The program delivers tailored educational materials and remote conferencing to patients and local oncology providers to increase awareness and streamline referral pathways. Enrollment targets adults with any cancer who live in specified Hawaii counties and who have not previously participated in a cancer clinical trial. The pilot will measure feasibility and changes in trial awareness and referral activity within participating rural sites.
Why it matters
Potential benefit: If successful, this program could increase awareness of and referrals to cancer clinical trials for rural patients, potentially giving them access to more treatment options.
How similar studies have gone: Previous education and telehealth interventions have shown promise increasing clinical trial awareness and referrals, though rural-focused pilots remain limited and results vary by setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients must have been diagnosed with any cancer. * Patients who have received treatment, are receiving cancer treatment at the time of enrollment, or estimated to start treatment within 90 days. * Patients must be ≥ 18 years of age. Patients must be able to read, write, and speak English. Study materials and telephone calls are only available in English. Patients must be residents of Hawaii, Kauai, or Maui counties. Exclusion Criteria: * Patients must not have previously participated in a cancer clinical trial. Those who have participated in a cancer clinical trial are not eligible for the study.
Where it's running
-
Hilo Benioff Medical Center
Hilo, Hawaii, United States Recruiting -
Univesity of Hawaii Cancer Center
Honolulu, Hawaii, United States Recruiting -
Wilcox Medical Center
Lihue, Hawaii, United States Recruiting
Study contacts
- Principal investigator: Izumi Okado, PhD — University of Hawaii Cancer Research Center
- Study coordinator: Izumi Okado, PhD
- Email: iokado@cc.hawaii.edu
- Phone: (808) 564-5978
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.